OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Showing 7 citing articles:
Immune‐Mediated Liver Injury From Checkpoint Inhibitor: An Evolving Frontier With Emerging Challenges
Lily Dara, Eleonora De Martin
Liver International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 2
Lily Dara, Eleonora De Martin
Liver International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 2
Analysis of risk factors for immune checkpoint inhibitor-associated liver injury: a retrospective analysis based on clinical study and real-world data
Bitao Wang, Shaowei Zhuang, Shengnan Lin, et al.
Hepatology International (2025)
Closed Access | Times Cited: 1
Bitao Wang, Shaowei Zhuang, Shengnan Lin, et al.
Hepatology International (2025)
Closed Access | Times Cited: 1
Drug induced cholestatic liver diseases
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Risk factors and prediction for DILI in clinical practice
Helgi K. Björnsson, Einar S. Björnsson
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Helgi K. Björnsson, Einar S. Björnsson
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Causal Association Between Circulating Inflammatory Proteins and Autoimmune Liver Disease: a Bidirectional Two-Sample Mendelian Randomization Study
Lina Leng, Minghao Yin, Tao Xu, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 279-289
Open Access
Lina Leng, Minghao Yin, Tao Xu, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 279-289
Open Access
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
Evangelos Triantafyllou, Cathrin Gudd, Lucia Possamai
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
Evangelos Triantafyllou, Cathrin Gudd, Lucia Possamai
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 2
Hepatobiliary complications of immune checkpoint inhibitors in cancer
Donna Zhuang, David Zhang, Stephen M. Riordan
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 955-970
Open Access
Donna Zhuang, David Zhang, Stephen M. Riordan
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 955-970
Open Access
